Pura Vida Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-100,000
Closed -$3.94M 220
2022
Q2
$3.94M Hold
100,000
0.23% 102
2022
Q1
$6.99M Sell
100,000
-25,000
-20% -$1.83M 0.23% 100
2021
Q4
$9.73M Sell
125,000
-110,000
-47% -$9.71M 0.35% 75
2021
Q3
$22.4M Buy
235,000
+186,300
+383% +$19.7M 0.68% 34
2021
Q2
$6.05M Buy
48,700
+18,700
+62% +$2.23M 0.19% 103
2021
Q1
$3.95M Buy
+30,000
New +$4.11M 0.11% 131
2020
Q1
Sell
-50,000
Closed -$4.62M 105
2019
Q4
$4.62M Buy
+50,000
New +$4.4M 0.41% 58
2019
Q2
Sell
-65,000
Closed -$5.63M 111
2019
Q1
$5.63M Buy
+65,000
New +$5.53M 0.8% 39

Other funds holding EXAS

Pura Vida Investments's EXAS Position: Q2 2024 in Review

Pura Vida Investments sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 481,910 shares — an estimated $33.3M sold.

Pura Vida Investments first reported a position in EXAS in Q4 2014 and held it in 4 quarters. The position peaked at $33.3M in Q1 2024. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Pura Vida Investments reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Pura Vida Investments sold 481,910 Exact Sciences shares in Q2 2024, an estimated $33.3M.
  • Pura Vida Investments first reported a position in Exact Sciences in Q4 2014 and held it in 4 quarters.
  • Pura Vida Investments's Exact Sciences position peaked at $33.3M in Q1 2024.
  • 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.